These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 8516778)

  • 1. In vitro methodologies for enhanced toxicity testing.
    DelRaso NJ
    Toxicol Lett; 1993 May; 68(1-2):91-9. PubMed ID: 8516778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overview of alternative methodologies in toxicology.
    Gribaldo L
    Curr Protoc Toxicol; 2007 Nov; Chapter 20():Unit20.1. PubMed ID: 20882519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In-vitro techniques: can they replace animal testing?
    Pearson RM
    Hum Reprod; 1986 Dec; 1(8):559-60. PubMed ID: 3818914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Charting a course for cell culture alternatives to animal testing.
    Goldberg L
    Fundam Appl Toxicol; 1986 May; 6(4):607-17. PubMed ID: 3519344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How omics technologies can contribute to the '3R' principles by introducing new strategies in animal testing.
    Kroeger M
    Trends Biotechnol; 2006 Aug; 24(8):343-6. PubMed ID: 16782220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toward preclinical predictive drug testing for metabolism and hepatotoxicity by using in vitro models derived from human embryonic stem cells and human cell lines - a report on the Vitrocellomics EU-project.
    Mandenius CF; Andersson TB; Alves PM; Batzl-Hartmann C; Björquist P; Carrondo MJ; Chesne C; Coecke S; Edsbagge J; Fredriksson JM; Gerlach JC; Heinzle E; Ingelman-Sundberg M; Johansson I; Küppers-Munther B; Müller-Vieira U; Noor F; Zeilinger K
    Altern Lab Anim; 2011 May; 39(2):147-71. PubMed ID: 21639679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro toxicity: mechanisms, alternatives and validation - a report from the 19th annual scientific meeting of the Scandinavian Society for Cell Toxicology.
    Forsby A
    Altern Lab Anim; 2002; 30(3):307-8. PubMed ID: 12106008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SEURAT-1 liver gold reference compounds: a mechanism-based review.
    Jennings P; Schwarz M; Landesmann B; Maggioni S; Goumenou M; Bower D; Leonard MO; Wiseman JS
    Arch Toxicol; 2014 Dec; 88(12):2099-133. PubMed ID: 25395007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Use of primary cultured hepatocytes for toxicology].
    Kohira T; Nakamura T
    J Toxicol Sci; 1989 Dec; 14 Suppl 3():108-14. PubMed ID: 2639199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alternatives to in vivo tests for teratologic screening.
    Prati M; Giavini E; Menegola E
    Ann Ist Super Sanita; 1993; 29(1):41-6. PubMed ID: 8129271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. From cells to QSAR: Alternative predictive models in toxicology.
    Sambuy Y; Bassi AM; Scanarotti C; Caloni F
    ALTEX; 2017; 34(1):168-171. PubMed ID: 28105479
    [No Abstract]   [Full Text] [Related]  

  • 12. Implementing Toxicity Testing in the 21st Century (TT21C): Making safety decisions using toxicity pathways, and progress in a prototype risk assessment.
    Adeleye Y; Andersen M; Clewell R; Davies M; Dent M; Edwards S; Fowler P; Malcomber S; Nicol B; Scott A; Scott S; Sun B; Westmoreland C; White A; Zhang Q; Carmichael PL
    Toxicology; 2015 Jun; 332():102-11. PubMed ID: 24582757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictive value of in vitro model systems in toxicology.
    Davila JC; Rodriguez RJ; Melchert RB; Acosta D
    Annu Rev Pharmacol Toxicol; 1998; 38():63-96. PubMed ID: 9597149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro toxicology in the light of new technologies.
    Fry J; George E
    Altern Lab Anim; 2001; 29(6):745-8. PubMed ID: 11764747
    [No Abstract]   [Full Text] [Related]  

  • 15. Induction, expression and maintenance of cytochrome P450 isoforms in long-term cultures of primary human hepatocytes.
    Yuan J; Liu L; Shimada M; Wang A; Ruhnke M; Heeckt P; Muller AR; Nussler NC; Neuhaus P; Nussler A
    ALTEX; 2004; 21 Suppl 3():3-11. PubMed ID: 15057403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of novel tools for the in vitro investigation of drug-induced liver injury.
    Jiang J; Wolters JE; van Breda SG; Kleinjans JC; de Kok TM
    Expert Opin Drug Metab Toxicol; 2015; 11(10):1523-37. PubMed ID: 26155718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coupling of computer modeling with in vitro methodologies to reduce animal usage in toxicity testing.
    Clewell HJ
    Toxicol Lett; 1993 May; 68(1-2):101-17. PubMed ID: 8516756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction and classification of drug toxicity using probabilistic modeling of temporal metabolic data: the consortium on metabonomic toxicology screening approach.
    Ebbels TM; Keun HC; Beckonert OP; Bollard ME; Lindon JC; Holmes E; Nicholson JK
    J Proteome Res; 2007 Nov; 6(11):4407-22. PubMed ID: 17915905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alternative methods in toxicology tests: in vitro toxicity.
    Cinelli S; Falezza A; Meli C; Ciliutti P; Vericat JA
    Cytotechnology; 1991; 5 Suppl 1():51-4. PubMed ID: 1367120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The long and winding road of progress in the use of in vitro data for risk assessment purposes: From "carnation test" to integrated testing strategies.
    Blaauboer BJ
    Toxicology; 2015 Jun; 332():4-7. PubMed ID: 24769060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.